Dr Reddys Laboratories Ltd vs Orchid Pharma Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 13, 2026

Key Highlights

The Latest Trading Price of Dr Reddys Laboratories Ltd is ₹ 1273 as of 12 Jun 15:30 . The P/E Ratio of Dr Reddys Laboratories Ltd changed from 38.5 on March 2021 to 16.9 on March 2025 . This represents a CAGR of -15.18% over 5 yearsThe P/E Ratio of Orchid Pharma Ltd changed from 33.9 on March 2023 to 39.5 on March 2025 . This represents a CAGR of 5.23% over 3 years The Market Cap of Dr Reddys Laboratories Ltd changed from ₹ 75095 crore on March 2021 to ₹ 95465 crore on March 2025 . This represents a CAGR of 4.92% over 5 yearsThe Market Cap of Orchid Pharma Ltd changed from ₹ 10061 crore on March 2021 to ₹ 3940 crore on March 2025 . This represents a CAGR of -17.10% over 5 years The revenue of Dr Reddys Laboratories Ltd for the Mar '26 is ₹ 8026 crore as compare to the Dec '25 revenue of ₹ 9024 crore. This represent the decline of -11.06% The revenue of Orchid Pharma Ltd for the Mar '26 is ₹ 245.49 crore as compare to the Dec '25 revenue of ₹ 212.88 crore. This represent the growth of 15.32% The ebitda of Dr Reddys Laboratories Ltd for the Mar '26 is ₹ 862.5 crore as compare to the Dec '25 ebitda of ₹ 2158 crore. This represent the decline of -60.04% The ebitda of Orchid Pharma Ltd for the Mar '26 is ₹ 34.75 crore as compare to the Dec '25 ebitda of ₹ 0.06 crore. This represent the growth of 57816% The net profit of Dr Reddys Laboratories Ltd changed from ₹ 1392 crore to ₹ 221.3 crore over 8 quarters. This represents a CAGR of -60.13% The net profit of Orchid Pharma Ltd changed from ₹ 28.27 crore to ₹ 22.79 crore over 8 quarters. This represents a CAGR of -10.21% The Dividend Payout of Dr Reddys Laboratories Ltd changed from 19.03 % on March 2021 to 12.47 % on March 2025 . This represents a CAGR of -8.11% over 5 yearsThe Dividend Payout of Orchid Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Dr Reddys Laboratories Ltd

Dr Reddy's Laboratories Limited (DRL) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives.
Through its three businesses - Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products - Dr. Reddy's portfolio of products and services include Active Pharmaceutical Ingredients (APIs), custom pharmaceutical services, generics, biosimilars and differentiated formulations.
The company's major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology.
Dr. Reddy's operates in markets across the globe.
Its major markets include - USA, India, Russia & CIS countries, and Europe. Dr Reddy's Laboratories Limited was incorporated in 1984 in Hyderabad.

About Orchid Pharma Ltd

Orchid Pharma Limited, is a vertically integrated pharmaceutical company with established research, manufacturing and marketing capabilities across multi-therapeutic domains.
Orchid's world class manufacturing infrastructure include USFDA compliant API and Finished Dosage Form facilities at Chennai in India.
The Company has dedicated state-of-art and GLP compliant R&D infrastructure for Process Research, Drug Discovery and Pharmaceutical Research at Chennai. The Company has a portfolio of antibiotics, and veterinary products.
Antibiotics are life-saving drugs used to ght infections.
Different classes of antibiotics include Beta-lactam, Macrolide, Fluoroquinolone, Imidazoleetc.

FAQs for the comparison of Dr Reddys Laboratories Ltd and Orchid Pharma Ltd

Which company has a larger market capitalization, Dr Reddys Laboratories Ltd or Orchid Pharma Ltd?

Market cap of Dr Reddys Laboratories Ltd is 106,328 Cr while Market cap of Orchid Pharma Ltd is 4,650 Cr

What are the key factors driving the stock performance of Dr Reddys Laboratories Ltd and Orchid Pharma Ltd?

The stock performance of Dr Reddys Laboratories Ltd and Orchid Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dr Reddys Laboratories Ltd and Orchid Pharma Ltd?

As of June 13, 2026, the Dr Reddys Laboratories Ltd stock price is INR ₹1273.9. On the other hand, Orchid Pharma Ltd stock price is INR ₹917.0.

How do dividend payouts of Dr Reddys Laboratories Ltd and Orchid Pharma Ltd compare?

To compare the dividend payouts of Dr Reddys Laboratories Ltd and Orchid Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.